Covid-19 roundup: Moderna starts lining up potential EU approval for vaccine; Hahn rejected White House push to rebrand EUA — Politico
Underscoring Moderna’s global ambitions for its Covid-19 vaccine, the company says that the EMA has confirmed its eligibility to file for marketing authorization using its centralized process. The move sets up a fast-track review process aimed at maneuvering through the regulatory group and onto the European market in speedy fashion — provided the data continue to line up.
Moderna is allied with Lonza on a manufacturing plan for Europe, looking to make 500 million to a billion doses a year, beginning in 2021.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 92,100+ biopharma pros reading Endpoints daily — and it's free.